Journal profile · Immunology
Immunologic Research
ISSN 0257-277X · eISSN 1559-0755 · Springer US · UNITED STATES · Bimonthly · Founded 1982
Immunologic Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.69; hybrid open access; APC about USD 2,890; median 94 days to acceptance (107 articles, last 24 months); community-reported acceptance: fairly easy; 153 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Immunologic Research is published by Springer US and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are T-cell and B-cell Immunology, Immune Cell Function and Interaction and Immunotherapy and Immune Responses, together about 45.9% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Immunologic Research represents a unique medium for the presentation, discussion and clarification of complex scientific data. The scope of the journal covers the entire spectrum of immunology from the molecular and cellular level to immunological diseases and clinical applications. By maintaining a balance between basic and clinical data Immunologic Research provides a platform for researchers, clinicians as well as experts from industry to bring laboratory findings into the clinics. Our journal also provides a platform to present historical reviews and landmark discoveries as well as to discuss novel measure to teach immunology during public events and in the class room. Submissions are welcomed in the form of original articles, reviews, brief communications, case reports, comments about recent findings reported in other journals and letters to the editor. Editorials, guidelines and new techniques of innovative importance are also encouraged. All submissions will be subjected to peer-review by independent reviewers and members of the Editorial Board. The scientific quality will be monitored and maintained by a Board of Editors with expertise in a broad spectrum of immunological subspecialties.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief Sakir AhmedPublisher website
Editorial board by country: none in mainland China; most named Italy 9, United States 3, Hong Kong, China 2, United Kingdom 1, India 1 (25 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- T-cell and B-cell ImmunologyImmunology and Microbiology17.6%
- Immune Cell Function and InteractionImmunology and Microbiology17.6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology10.7%
- Immune Response and InflammationImmunology and Microbiology6.1%
- Monoclonal and Polyclonal Antibodies ResearchMedicine5.4%
- Systemic Lupus Erythematosus ResearchMedicine5%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology4.4%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.69LetPub ·
- Impact factor (publisher) 2025
- 2.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.1Publisher website ·
- CiteScore 2026-06
- 4.6LetPub ·
- SJR 2026-06
- 0.75LetPub ·
- SNIP 2026-06
- 0.7LetPub ·
- h-index
- 77LetPub ·
- h-index
- 124OpenAlex ·
- i10-index
- 1,698OpenAlex ·
- 2-year mean citedness
- 2.76OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 24.28%LetPub ·
Volume
- Articles per year
- 155LetPub ·
- Downloads per year (publisher) 2025
- 580,800Publisher website ·
Articles by year OpenAlex count · 2,821 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 116 | 27 | 34 |
| 2025 | 153 | 36 | 454 |
| 2024 | 125 | 36 | 601 |
| 2023 | 92 | 32 | 948 |
| 2022 | 99 | 47 | 1,392 |
| 2021 | 85 | 41 | 1,735 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
94 daysMedian, submission to acceptance · P25–P75 64 days – 157 days
- Acceptance to online
- median 14 days (107 articles)
- Submission to online
- median 117 days
- Sample
- 107 articles with submission and acceptance dates (190 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,890 / EUR 4,390 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship Policy
Authorship should incorporate and should be restricted to those who have contributed substantially to the work in one or more of the following categories: • Conceived of or designed study • Performed research • Analyzed data • Contributed new methods or models • Wrote the paper Back to top
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Immunologic Research, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1982
- ISSN
- 0257-277X
- Electronic ISSN
- 1559-0755
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Immunologic Research
What CAS zone is Immunologic Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immunologic Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Immunologic Research?
The latest impact factor listed by LetPub is 2.69; CiteScore 4.6, h-index 124.
How long does peer review take at Immunologic Research?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 94 days (interquartile range 64–157 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Immunologic Research?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Immunologic Research based?
Of the 25 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (9), United States (3) and Hong Kong, China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Immunologic Research?
According to LetPub and DOAJ records, Immunologic Research is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Immunologic Research open access, and what is the APC?
Immunologic Research is a hybrid journal. For open-access publication: APC about USD 2,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .